Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Surfolase CR PK in Healthy Volunteers
NCT02373891Phase 1Completed
- Sponsor
- Hyundai Pharmaceutical Co., Ltd.
- Start
- Apr 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of acebrophylline in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Hyundai Pharmaceutical Co., Ltd. Primary endpoints: Ambroxol Area Under the Curve from time zero to last measurable concentration, Ambroxol Maximum Plasma Concentration and 3 more. Started Apr 2014; status: completed.
02
Drugs
acebrophylline
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02373891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373891.